Xaparin 40
Form: Injection
Strength: 40mg/0.4ml
Generic Name: Enoxaparin Sodium
Company: The ACME Laboratories Ltd.
MRP:৳ 440.0 (0.4ml PF syringe)
Is Antibiotic: No
Indications
Xaparin 40 is used for treating deep vein thrombosis (DVT), with or without lung blood clots (pulmonary embolism). Xaparin 40 is also used for treating unstable angina and non-Q-wave heart attack along with aspirin. Xaparin 40 helps prevent blood clots during hemodialysis and is used to prevent venous blood clot formation, especially after surgeries or in bedridden patients due to serious illness.
Pharmacology
Xaparin 40 is a low molecular weight heparin that works mainly by blocking certain factors in the blood clotting process. At the correct doses, Xaparin 40 does not cause increased bleeding and does not change blood clotting times significantly. Xaparin 40 is processed in the liver.
Dosage & Administration
For DVT treatment: Injected under the skin, 100 anti-Xa IU/kg twice a day for 10 days, or 150 anti-Xa IU/kg once a day for 10 days. Switch to oral anticoagulants once appropriate.
For unstable angina and non-Q-wave heart attack: Injected under the skin, 100 anti-Xa IU/kg twice a day for 2 to 8 days, along with aspirin.
For hemodialysis: Inject 100 anti-Xa IU/kg at the start of the dialysis. In high-risk patients, reduce the dose to 50 or 75 anti-Xa IU/kg, depending on the type of access used.
For surgical patients: In general surgery, inject 2000 anti-Xa IU once daily for 7 to 10 days, starting 2 hours before surgery. For orthopedic surgery, inject 4000 anti-Xa IU once daily, starting 12 hours before surgery, with the possibility of extending treatment.
For medical patients: Inject 4000 anti-Xa IU once daily for 6 to 14 days.
Interaction
Avoid using medications that affect blood clotting, such as aspirin, NSAIDs, and other anticoagulants, unless absolutely necessary. If used together, careful monitoring is required.
Contraindications
Xaparin 40 is not safe for patients who are allergic to Xaparin 40, heparin, or other similar drugs. Xaparin 40 should not be used by patients with active major bleeding or a high risk of bleeding, such as those with a recent hemorrhagic stroke.
Side Effects
Side effects may include bleeding, low platelet count, elevated liver enzymes, pain, or bruising at injection sites. Serious side effects like nerve damage may occur if used with spinal anesthesia.
Pregnancy & Lactation
Xaparin 40 is categorized as safe during pregnancy (Category B) but should only be used if necessary. There is no evidence Xaparin 40 crosses the placenta, but always consult a doctor. Xaparin 40 is unknown if Xaparin 40 passes into breast milk, so a decision should be made whether to continue breastfeeding or stop the drug, considering the risks and benefits.
Precautions & Warnings
Xaparin 40 should be injected under the skin for most treatments and into the blood during hemodialysis. Xaparin 40 should not be injected into the muscle. Use Xaparin 40 with caution in patients who have bleeding risks, such as those with ulcers, recent strokes, or diabetes. Regular platelet checks are recommended during treatment.
Overdose Effects
Overdose can cause bleeding. If this happens, Xaparin 40 can be treated with protamine sulfate to neutralize the drug. The dose of protamine should match the amount of the drug given.
Therapeutic Class
Xaparin 40 belongs to the class of parenteral anticoagulants, which are used to prevent blood clots.
Storage Conditions
Store in a cool, dry place, away from light and moisture. Do not store above 25°C or in the fridge or freezer. Keep out of reach of children.
Similar Brands of Enoxaparin Sodium (Injection – 40mg/0.4ml)
| Brand Name | Form | Strength | Company | MRP (৳) |
|---|---|---|---|---|
| Alexa 40 | Injection | 40mg/0.4ml | Healthcare Pharmaceuticals Ltd. | 450.0 |
| Cardinex 40 | Injection | 40mg/0.4ml | Drug International Ltd. | 425.0 |
| Claxo 40 | Injection | 40mg/0.4ml | General Pharmaceuticals Ltd. | 351.06 |
| Cleven 40 | Injection | 40mg/0.4ml | Beximco Pharmaceuticals Ltd. | 450.0 |
| Clotinex 40 | Injection | 40mg/0.4ml | Square Pharmaceuticals Ltd. | 451.36 |
| Enoma 40 | Injection | 40mg/0.4ml | Biopharma Ltd. | 400.0 |
| Enoparin 40 | Injection | 40mg/0.4ml | Popular Pharmaceuticals Ltd. | 460.0 |
| Enorin 40 | Injection | 40mg/0.4ml | Eskayef Pharmaceuticals Ltd. | 450.0 |
| Eparin 40 | Injection | 40mg/0.4ml | Beacon Pharmaceuticals Ltd. | 450.0 |
| Intravas 40 | Injection | 40mg/0.4ml | Aristopharma Limited | 400.0 |
| Noxarin 40 | Injection | 40mg/0.4ml | Opsonin Pharma Limited | 400.0 |
| Ovenox 40 | Injection | 40mg/0.4ml | Sanofi Bangladesh Ltd. | 461.38 |
| Parinox 40 | Injection | 40mg/0.4ml | Incepta Pharmaceuticals Ltd. | 450.0 |
| Vistarin 40 | Injection | 40mg/0.4ml | ACI Limited | 425.0 |